Search Results - "SCHWARZINGER, I"

High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) by SIMANEK, R., VORMITTAG, R., AY, C., ALGUEL, G., DUNKLER, D., SCHWARZINGER, I., STEGER, G., JAEGER, U., ZIELINSKI, C., PABINGER, I.

“…Background: In cancer patients, laboratory parameters that predict venous thromboembolism (VTE) are scarce. Increased platelet count has been found to be a…”
Get full text

Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network by Füreder, Wolfgang, Sperr, W. R., Heibl, S., Zebisch, A., Pfeilstöcker, M., Stefanzl, G., Jäger, E., Greiner, G., Schwarzinger, I., Kundi, M., Keil, F., Hoermann, G., Bettelheim, P., Valent, P.

“…Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematologic disease characterized by a deregulated complement system, chronic Coombs-negative,…”
Get full text

Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells by Grisar, J., Steiner, C. W., Bonelli, M., Karonitsch, T., Schwarzinger, I., Weigel, G., Steiner, G., Smolen, J. S.

“…Objective. SLE is characterized by an increased cardiovascular risk. Since endothelial progenitor cells (EPCs) have been described to serve as a biomarker for…”
Get full text

High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia by HEINTEL, D, KIENLE, D, CHOTT, A, SCHWARZMEIER, J, FONATSCH, C, GAIGER, A, DÖHNER, H, STILGENBAUER, S, JÄGER, U, SHEHATA, M, KRÖBER, A, KROEMER, E, SCHWARZINGER, I, MITTEREGGER, D, LE, T, GLEISS, A, MANNHALTER, C

“…We investigated the pattern of lipoprotein lipase (LPL) expression in B-cell chronic lymphocytic leukemia (B-CLL) and assessed its prognostic relevance…”
Get full text

Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12 by Porpaczy, E., Bilban, M., Heinze, G., Gruber, M., Vanura, K., Schwarzinger, I., Stilgenbauer, S., Streubel, B., Fonatsch, C., Jaeger, U.

“…Background  The prognosis of chronic lymphocytic leukaemia (CLL) patients is largely determined by the karyotype of the malignant clone. We have investigated…”
Get full text

Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes by Wimazal, F., Sperr, W. R., Kundi, M., Vales, A., Fonatsch, C., Thalhammer-Scherrer, R., Schwarzinger, I., Valent, P.

“…Background: Early recognition of disease progression in low-risk myelodysplastic syndromes (MDS) is an important decision point concerning intensive therapies…”
Get full text

The new hematology analyzer Sysmex XE-2100: performance evaluation of a novel white blood cell differential technology by Ruzicka, K, Veitl, M, Thalhammer-Scherrer, R, Schwarzinger, I

“…The new hematology analyzer Sysmex XE-2100 (TOA Medical Electronics, Kobe, Japan) has a novel, combined, white blood cell differential technology and a special…”
Get full text

High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia by HEINTEL, D, KROEMER, E, STILGENBAUER, S, DÖHNER, H, FONATSCH, C, JÄGER, U, KIENLE, D, SCHWARZINGER, I, GLEISS, A, SCHWARZMEIER, J, MARCULESCU, R, LE, T, MANNHALTER, C, GAIGER, A

“…Activation-induced cytidine deaminase (AID) is essential for somatic hypermutation of B-cells. We investigated the expression of AID mRNA by real-time…”
Get full text

Sequential gene expression profiling during treatment for identification of predictive markers and novel therapeutic targets in chronic lymphocytic leukemia by Shehata, M, Demirtas, D, Schnabl, S, Hilgarth, M, Hubmann, R, Fonatsch, C, Schwarzinger, I, Hopfinger, G, Eigenberger, K, Heintel, D, Porpaczy, E, Vanura, K, Hauswirth, A, Schwarzmeier, J D, Gaiger, A, Stilgenbauer, S, Hallek, M, Bilban, M, Jäger, U

Get full text

Dasatinib inhibits progenitor cell proliferation from polycythaemia vera by Wappl, M., Jaeger, E., Streubel, B., Gisslinger, H., Schwarzinger, I., Valent, P., Oehler, L.

“…Background  A mutation of Janus kinase 2 V617F is present in most patients with polycythaemia vera (PV). However, it is generally believed that JAK2V617F is…”
Get full text

Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy by Aichberger, K. J., Herndlhofer, S., Agis, H., Sperr, W. R., Esterbauer, H., Rabitsch, W., Knöbl, P., Haas, O. A., Thalhammer, R., Schwarzinger, I., Sillaber, C., Jäger, U., Valent, P.

“…Background  Central nervous system (CNS) relapse in chronic myeloid leukaemia (CML) is rare and if recorded is usually found to occur in patients with…”
Get full text

In vivo effects of imatinib mesylate on human haematopoietic progenitor cells by Agis, H., Jaeger, E., Doninger, B., Sillaber, C., Marosi, C., Drach, J., Schwarzinger, I., Valent, P., Oehler, L.

“…Background  Imatinib mesylate has considerable antineoplastic activity in patients with chronic myeloid leukaemia (CML) and some solid tumours. Although…”
Get full text

A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis by AGIS, H, WELTERMANN, A, JÄGER, U, LECHNER, K, GEISSLER, K, FONATSCH, C, HAAS, O, MITTERBAUER, G, MÜLLAUER, L, SCHREIBER, S, SCHWARZINGER, I, JURETZKA, W, VALENT, P

“…We studied the incidence of leukemia cutis (LC) in 381 consecutive patients with acute myeloid leukemia (AML) in a single institution and compared the…”
Get full text

Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse by WELTERMANN, A, FONATSCH, C, SPERR, W. R, KNÖBL, P, SCHWARZINGER, I, GLEISS, A, LECHNER, K, HAAS, O. A, GREINIX, H. T, KAHLS, P, MITTERBAUER, G, JÄGER, U, KAINZ, B, GEISSLER, K, VALENT, P

“…Karyotype is an important prognostic factor in patients with newly diagnosed acute myeloblastic leukaemia (AML). The prognostic value of cytogenetics on the…”
Get full text

Remission of pure red cell aplasia in T-cell receptor γδ-large granular lymphocyte leukemia after therapy with low-dose alemtuzumab by SCHÜTZINGER, C, GAIGER, A, THALHAMMER, R, VESOLY, M, FRITSCHE-POLANZ, R, SCHWARZINGAR, I, ÖHLER, L, SIMONITSCH-KLUPP, I, REINHARD, F, JÄGER, U

Get full text

Targeting the dust by Exner, M., Schwarzinger, I.

Get full text

Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c‐kit mutation Asp‐816 to Val by Sperr, W R, Walchshofer, S, Horny, H P, Födinger, M, Simonitsch, I, Fritsche-Polanz, R, Schwarzinger, I, Tschachler, E, Sillaber, C, Hagen, W, Geissler, K, Chott, A, Lechner, K, Valent, P

“…A subset of patients with systemic mastocytosis (SM) develop acute myeloid leukaemia (AML). However, little is known about the biology of such leukaemias and…”
Get full text

P103 Prognostic significance of LDH as a dynamic variable in myelodysplastic syndromes by Sperr, W.R, Wimazal, F, Vales, A, Kundi, M, Böhm, A, Thalhammer, R, Schwarzinger, I, Valent, P

Get full text

P006 Idiopathic cytopenia of uncertain significance (ICUS) versus low risk MDS: the diagnostic interface by Valent, P, Wimazal, F, Fonatsch, C, Thalhammer, R, Schwarzinger, I, Müllauer, L, Sperr, W.R, Bennett, J.M

Get full text

The Häma-COM laboratory data management system (LDS) : Tailor-made computerization of the individual working procedures arising in a hematology laboratory with a high throughput of pathologic samples by SCHWARZINGER, I

“…A laboratory data management system (Häma-COM) is presented that is individually adaptable to the different working procedures arising in a hematology…”
Get full text